Fingerprint
Dive into the research topics of 'GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
Nir Peled*, Roni Gillis, Saadettin Kilickap, Patrizia Froesch, Sergei Orlov, Elena Filippova, Umut Demirci, Petros Christopoulos, Irfan Cicin, Fatma Bugdayci Basal, Cengiz Yilmaz, Moiseenko Fedor, Taner Korkmaz, Semra Paydas, Oliver Gautschi, Alisan Zirtiloglu, Yesim Eralp, Havva Yesil Cinkir, Ahmet Sezer, Mustafa Erman
*Corresponding author for this work
- Soroka Medical Center
- Ben-Gurion University of the Negev
- Hacettepe University
- Oncology Institute of Southern Switzerland
- Pavlov First State Medical University of St. Petersburg
- Uskudar University
- Heidelberg University
- Trakya University
- University of Health Sciences
- Ege University
- N.N. Petrov National Medical Research Center of Oncology
- St. PetersburgClinical Research and Practical Center for Specialized Types of Medical Care (Oncologic)
- Acibadem Mehmet Ali Aydinlar Universitesi
- Cukurova University
- University of Bern
- Bakirkoy Sadi Konuk Training and Research Hospital
- Gaziantep University
- Baskent University
- Istanbul University - Cerrahpaşa
- CHU de Toulouse
- Rabin Medical Center Israel
- August Pi i Sunyer Biomedical Research Institute
- University of Colorado Anschutz Medical Campus
- Ankara University
- Afyon Kocatepe University
- Yildirim Beyazit Universitesi
- Dokuz Eylul University
- Medicalpark Bahçelievler Hospital
- Akdeniz University
- Dicle University
- Kocaeli University
- Marmara University
- Istanbul Medipol University
- Ankara Numune Education and Research Hospital
- Istanbul University
- Adnan Menderes University
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations